Company news

Guobang Pharma Ltd. news in 2024

Guobang Pharma Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Announcement on the Passing of U.S. FDA On-site Inspection of Florfenicol, a Wholly-owned Subsidiary's Product

December 19, 2024

Announcement on the Progress of Providing Guarantees for Subsidiary

December 8, 2024

Announcement on the Results of Shareholding Reduction by Shareholders

November 29, 2024